PO&T Commercial Asset Development Leader
Baar - Switzerland
Job Summary
About This Role
The PO&T Commercial Asset Development Leader is a member of the Asset Development & Portfolio Management (ADPM) team which provides cross-functional guidance across PO&Ts line functions for commercial assets. The role oversees and owns various aspects of the asset management development related to asset strategy development supply and life cycle management planning support for the commercial program. This role also represents and provides critical input and considerations to R&D and PDC teams regarding life cycle management activities from the PO&T perspective. This is a high-impact highly visible leadership role with significant influence on asset value creation and portfolio decisions.
This is a hybrid role that could be based in Cambridge RTP NC or Baar Switzerland.
What Youll Do
- Oversee the development and implementation of a 5-year PO&T Asset Strategy and maintain an 18-month rolling Tactical Plan ensuring alignment with overall company objectives enabling the PO&T Leadership team to take an informed decision on the asset.
- Lead the cross-functional PO&T Asset Team comprising representatives from each PO&T Line Function to ensure cohesive and effective execution of the PO&T Asset Strategy & Tactical Plan.
- Act as the liaison and representative for PO&T on R&D Program teams and PDC teams fostering collaboration and communication between R&D Commercial and PO&T to support asset(s).
- Pro-actively address and manage conflicts related to the Asset Strategy in consultation with the PO&T Governance Committee ensuring that PO&T Line Functions priorities are balanced with the needs of the Asset Strategy.
- Track and assess asset-related impacts on financial metrics such as COGS E&O and OPEX and work with PO&T Line Functions to develop strategies for improvement.
- Develop business cases for significant Asset initiatives and secure endorsement and approval from the PO&T Governance Committee.
Qualifications
- BS or equivalent in Sciences/Eng with an advanced degree (MS PhD MBA) preferred in a relevant biopharmaceutical discipline
- Minimum of 12 years experience with a focus on matrix management.
- Track record of effective matrix leadership experience in the setting of program teams across the full product life cycle e.g. (CMC) PO&T line functions sub-teams or other cross-functional teams operating in a matrix environment ideally across an organization
- Alliance management experience preferably global; understanding of business contracts and management
- Experience with CMC supply chain or LCM development extending from IND to NDA/BLA including a solid understanding of global registration processes. Technical expertise in a relevant biopharmaceutical development discipline
- Experience in healthcare/biotech/pharmaceutical industry with a demonstrated understanding of cross-functional interdependencies (i.e. R&D commercial technical development regulatory)
- Excellent strategic political organizational and relationship development skills
- Demonstrated ability to lead motivate influence without authority a strategic direction; ability to effectively leverage and develop diverse perspectives and ideas from matrix teams and others.
- Excellent communication negotiation problem solving and decision-making abilities
- Demonstrated ability to identify critical program risks and develop mitigation plans strategic or tactical to mitigate risk costs and reputation of Biogen.
Who You Are
You are a seasoned leader with in-depth experience in drug development supply chain or manufacturing. You will be part of ADPM and lead teams representing PO&T disciplines and maintain critical partnerships with relevant program R&D and/or product commercial leaders. You will be instrumental in leading and facilitating key aspects of the PO&T vision including Influence & Collaborations through engagement with/oversight of collaborations and interface with BD and External Innovation; Data Access and Connectivity by driving best practices for resource management/forecasting decision gates and associated knowledge management initiatives.
Why This Role
This role offers a unique opportunity to:
- Own and shape asset strategy at a critical stage of the lifecycle
- Operate at the intersection of science operations and commercial value
- Influence enterprise-level decisions and portfolio outcomes
- Lead in a highly visible cross-functional environment
Why Biogen
We are a global team with a commitment to excellence and a pioneering spirit. As a mid-sized biotechnology company we provide the stability and resources of a well-established business while fostering an environment where individual contributions make a significant impact. Our team encompasses some of the most talented and passionate achievers who have unparalleled opportunities for learning growth and expanding their skills. Above all we work together to deliver life-changing medicines with every role playing a vital part in our mission. Caring Deeply. Achieving Excellence. Changing Lives.
At Biogen we are committed to building on our culture of inclusion and belonging that reflects the communities where we operate and the patients we serve. We know that diverse backgrounds cultures and perspectives make us a stronger and more innovative company and we are focused on building teams where every employee feels empowered and inspired.Read onto learn more about our DE&I efforts.
All qualified applicants will receive consideration for employment without regard to sex gender identity or expression sexual orientation marital status race color national origin ancestry ethnicity religion age veteran status disability genetic information or any other basis protected by federal state or local law. Biogen is an E-Verify Employer in the United States.
About Company
Founded in 1978, Biogen is a leading biotechnology company that pioneers innovative science to deliver new medicines to transform patients lives and to create value for shareholders and our communities. We apply deep understanding of human biology and leverage different modalities, ... View more